Client Resource, Health Markers
Normal is not the same as optimal. Most people with elevated blood pressure have lifestyle factors that are more effective than medication. Here is the evidence.
Blood pressure is the force exerted by circulating blood on the walls of blood vessels. It is expressed as two numbers: systolic (the pressure when the heart contracts) over diastolic (the pressure when the heart relaxes). Elevated blood pressure, hypertension, is the single largest modifiable risk factor for stroke, coronary heart disease, heart failure, kidney disease, and all-cause mortality globally. It affects approximately one third of UK adults, and roughly half of those are undiagnosed.
The relationship between blood pressure and cardiovascular risk is continuous and begins well below the clinical threshold for hypertension (140/90 mmHg). Risk increases progressively from 115/75 mmHg upwards, meaning that the difference between 120/80 and 130/85 is clinically meaningful even though neither would trigger treatment in standard practice. Understanding this is important because the lifestyle interventions that prevent blood pressure rising are far more effective than those that reverse established hypertension.
The SPRINT trial (9,361 participants) found that treating systolic blood pressure to below 120 mmHg (versus the standard target of below 140 mmHg) reduced cardiovascular events by 25% and all-cause mortality by 27%. This trial redefined the treatment target debate. (SPRINT Research Group, NEJM 2015)
Current UK and American guidelines classify blood pressure as: Normal (<120/80 mmHg), Elevated (120–129/<80 mmHg), Stage 1 hypertension (130–139/80–89 mmHg), and Stage 2 hypertension (≥140/90 mmHg). What the classifications do not convey is that cardiovascular risk begins rising at systolic pressure of 115 mmHg, well into the range considered normal. The Lewington et al. meta-analysis of 61 prospective studies covering one million adults found that each 20 mmHg increase in systolic or 10 mmHg increase in diastolic pressure above 115/75 mmHg doubles the risk of cardiovascular death. This is why optimal blood pressure, below 120/80, is meaningfully different from merely normal.
Measurement quality matters: White coat hypertension (elevated readings in clinical settings) is real and prevalent. Resting home measurements taken after 5 minutes of quiet sitting, on two or more occasions, are more reliable than single clinical readings. Morning resting blood pressure is the most clinically relevant measurement.
Exercise is the most evidence-backed non-pharmacological intervention for blood pressure reduction. A 2013 meta-analysis by Cornelissen and Smart covering 93 RCTs found that endurance training reduced systolic blood pressure by an average of 3.5 mmHg and diastolic by 2.5 mmHg. Resistance training reduced systolic by 1.8 mmHg and diastolic by 3.2 mmHg. Combined aerobic and resistance training produced the largest reductions. These numbers may appear modest but a 5 mmHg reduction in systolic blood pressure at a population level is associated with a 14% reduction in stroke mortality and 9% reduction in coronary heart disease mortality. For individuals with blood pressure in the 130–149 mmHg range, exercise alone can achieve clinically meaningful reductions without medication.
Optimal exercise prescription for blood pressure: Aerobic exercise at moderate intensity (zone 2), 3–5 sessions weekly of 30–45 minutes. Resistance training 2–3 sessions weekly. Isometric exercises (wall sits, plank holds) have shown surprisingly large blood pressure reductions in recent meta-analyses, isometric handgrip training at 30% MVC for 4 sets of 2 minutes produced average reductions of 6.8/4.0 mmHg across trials.
The relationship between dietary sodium intake and blood pressure is real but heterogeneous. On average, reducing sodium intake by 1,000 mg/day (roughly halving typical UK intake) reduces systolic blood pressure by approximately 3–4 mmHg in hypertensive individuals and 1–2 mmHg in normotensive individuals. The response is highly individual: salt-sensitive individuals (more common in older adults, people of African descent, and those with chronic kidney disease) show much larger reductions. Salt-insensitive individuals may show minimal response. The average effect size is modest and often overstated in public health messaging, but for high-sodium consumers with established hypertension, reduction is a worthwhile intervention.
Practical target: UK adults consume approximately 8g of salt (3,200 mg sodium) daily on average; the recommended maximum is 6g (2,400 mg sodium). Most dietary sodium comes from processed foods, bread, and restaurant meals rather than added table salt.
The blood pressure evidence for dietary potassium is as strong as for sodium, yet it receives far less attention. Potassium promotes renal sodium excretion, counterbalancing sodium's blood pressure-raising effects. A meta-analysis found that increased potassium intake reduced systolic blood pressure by 3.5 mmHg in hypertensive individuals, with effects independent of sodium intake. The DASH diet. the most evidence-backed dietary pattern for blood pressure reduction, achieves much of its effect through high potassium content (from vegetables, fruit, legumes, and dairy) rather than sodium restriction alone. Dietary potassium intake in UK adults is typically below recommended levels.
High-potassium foods: Potatoes, sweet potatoes, beans and lentils, bananas, avocado, spinach, broccoli, dairy products. Most whole foods are good sources; most ultra-processed foods are poor sources. This is another reason why diet quality, not specific nutrient restriction, is the more effective intervention.
Among lifestyle factors, excess body weight, particularly visceral adiposity, has the largest effect on blood pressure. Each kilogram of body weight reduction produces approximately 1 mmHg reduction in systolic blood pressure, with greater effects in those who are more overweight and who have higher starting blood pressure. Visceral fat drives blood pressure through multiple mechanisms: activation of the renin-angiotensin-aldosterone system, increased sympathetic nervous system activity, reduced kidney sodium excretion, and endothelial dysfunction. This is why waist-to-height ratio and blood pressure track closely in population data, and why resistance training combined with improved body composition produces larger blood pressure reductions than aerobic exercise alone.
The most effective combined intervention: Moderate calorie deficit to reduce central adiposity, adequate protein to preserve muscle mass, progressive resistance training, and regular aerobic exercise. This combination addresses blood pressure through four independent pathways simultaneously.
The relationship between alcohol consumption and blood pressure is dose-dependent above approximately one drink per day. Meta-analyses consistently find that consumption above 2 standard drinks (20g alcohol) per day raises systolic blood pressure by approximately 3.5–5 mmHg compared to non-drinkers. Heavy drinking (>5 drinks/day) raises systolic pressure by 7–10 mmHg. The mechanism involves activation of the sympathetic nervous system, cortisol release, and disruption of baroreceptor reflex sensitivity. For individuals with blood pressure at the high end of normal or in Stage 1 hypertension, alcohol reduction is one of the highest-yield single lifestyle modifications available.
Practical note: The cardiovascular risks of regular alcohol consumption are increasingly recognised as beginning at lower doses than previously thought. The blood pressure signal is present even at moderate intake in sensitive individuals.
Antihypertensive medications, ACE inhibitors, ARBs, calcium channel blockers, thiazide diuretics, are effective, well-tolerated, and clearly indicated for Stage 2 hypertension and for Stage 1 hypertension with additional cardiovascular risk factors. The evidence does not support lifestyle modification as a replacement for indicated medication. It supports the combination of both, and the prevention of reaching medication thresholds through earlier lifestyle intervention. Medication reduces blood pressure by 10–15 mmHg typically; lifestyle interventions can achieve 5–10 mmHg reductions. Combined, the reductions are additive and the cardiovascular risk reduction is substantially greater than either alone.
Clinical note: If your blood pressure is consistently above 140/90 mmHg, discuss with your GP. This resource is informational and does not constitute medical advice. Lifestyle intervention can reduce or eliminate the need for medication in some individuals with Stage 1 hypertension, but should always be discussed with a clinician.
Blood pressure is silent until it is not. Most people with elevated blood pressure have no symptoms until they have a stroke or cardiac event. A resting home blood pressure reading is the single most useful health marker you can measure yourself, for free, in under five minutes.
If yours is above 120/80 mmHg, the lifestyle interventions, exercise, body composition, sodium awareness, alcohol reduction, can meaningfully reduce it without immediate medication in many cases. If it is above 140/90 mmHg, discuss it with your GP. The data on what happens to people who do not address hypertension is consistent and sobering.
Book The Benchmark →SPRINT Research Group, A randomised trial of intensive versus standard blood-pressure control. NEJM 2015;373:2103–2116. 9,361 participants. The trial that redefined treatment targets.
Cornelissen VA, Smart NA, Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc 2013;2(1):e004473. 93 RCTs. Quantified aerobic and resistance training effects.
Whelton PK et al., Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 1997;277(20):1624–1632. Potassium and blood pressure reduction.
Lewington S et al., Age-specific relevance of usual blood pressure to vascular mortality. The Lancet 2002;360(9349):1903–1913. One million adults. Continuous risk relationship from 115/75 mmHg.
Fagard RH, Exercise is good for your blood pressure: effects of endurance training and resistance training. Clin Exp Pharmacol Physiol 2006;33(9):853–856. Review of exercise modalities and blood pressure outcomes.